Lataa...
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous PSA measurement, Clinical Stage and biopsy Gleason score
OBJECTIVE: Current 2007 Partin Tables restricts the application of total PSA (tPSA) as a non-continuous biomarker by creating “groups” for the risk stratification with tPSA value of 0-2.5, 2.6-4.0, 4.1-6.0, 6.1-10.0, and >10.0 ng/ml. Hence we developed a “2010 Partin Nomogram” with tPSA as a cont...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3082635/ https://ncbi.nlm.nih.gov/pubmed/20875091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2010.09692.x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|